Picard Medical released FY2024 Semi-Annual earnings on November 12, 2024 (EST), actual revenue USD 2.674 M, actual EPS USD -0.9238

Brief Summary

Picard Medical reported its 2024 fiscal half-year results, showing a revenue of 2.67 million USD and an EPS of -0.9238 USD per share, indicating a loss of 7.339 million USD.

Impact of The News

Picard Medical’s financial briefing presents several indicators of its business status:

1. Revenue:

• Picard Medical’s revenue for the first half of 2024 was 2.67 million USD. This figure is relatively low compared to other companies mentioned in the references, such as Agora, Inc. which reported second-quarter revenue of 34.26 million USD .

2. Earnings Per Share (EPS):

• The EPS for Picard Medical stands at -0.9238 USD, indicating a loss per share. This is a critical indicator as it shows the company’s current financial health and profitability.

3. Net Loss:

• The company reported a net loss of 7.339 million USD. This is concerning as it highlights the financial struggles of Picard Medical.

4. Comparison to Peers:

• Comparing Picard Medical to other companies, such as Kandi Technologies, which reported a net profit of 1.7 million USD for the first half of 2025, Picard Medical’s performance is significantly below the industry average .

5. Trend Analysis:

• Given the substantial loss and negative EPS, Picard Medical is facing financial distress. This could impact its ability to invest in new projects, pay dividends, and maintain investor confidence. If the trend of losses continues, it might necessitate strategic shifts, cost-cutting measures, or seeking additional funding.

6. Business Development Trends:

• The negative financial indicators suggest that Picard Medical may need to reassess its operational strategies, perhaps focusing on cost efficiency or diversifying its revenue streams. Future business development may hinge on successfully mitigating losses and improving profitability.

The financial briefing underscores Picard Medical’s need to address its current financial challenges to stabilize and grow in the competitive market.